Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest Labs profit dives on massive charge for DOJ probe
Marketwatch
Tuesday, April 21, 2009 - 8:44am
tags:
Forest Labs, earnings, DOJ
Sanofi Will Invest in China to Make Insulin Devices
Bloomberg
Tuesday, April 21, 2009 - 7:47am
tags:
Sanofi, China, insulin injectables
FDA, Clinical Trial Calendar Updates: Thoratec, Allos Therapeutics
Seeking Alpha
Tuesday, April 21, 2009 - 7:46am
tags:
FDA, drug trials, Allos, Thoratec
GlaxoSmithKline and Pfizer's HIV Drug Business Merger: An Industry Shift?
Seeking Alpha
Tuesday, April 21, 2009 - 7:45am
tags:
GSK, Pfizer, partnerships, HIV
Merck Profit Falls, Misses Expectations
CNBC
Tuesday, April 21, 2009 - 7:44am
tags:
Merck, earnings
Merck to license infection drug for up to $225 million
Marketwatch
Tuesday, April 21, 2009 - 6:53am
tags:
Merck, anti-infectives, licensing, Medarex
Schering-Plough profit jumps on Organon accounting changes
Marketwatch
Tuesday, April 21, 2009 - 6:52am
tags:
Schering Plough, earnings
FDA, Clinical Trial Calendar Updates: Discovery, Impax Labs
Seeking Alpha
Tuesday, April 21, 2009 - 6:33am
tags:
Impax Labs, FDA, drug trials, Discovery Labs, Surfaxin
Icahn Has a Match in Mind for Amylin. Well, Maybe
WSJ Online
Monday, April 20, 2009 - 5:20pm
tags:
Amylin, Carl Icahn, Eli Lilly
Drug stocks flee into negative territory
Marketwatch
Monday, April 20, 2009 - 4:32pm
tags:
drug stocks
A Cheer and a Boo for Eli Lilly
Motley Fool
Monday, April 20, 2009 - 4:29pm
tags:
Eli Lilly, earnings, patents
Report: Pharma deals in 1Q exceed all 2008 deals
Yahoo/AP
Monday, April 20, 2009 - 4:29pm
tags:
pharma industry, M&A
Earnings Preview: Merck
Seeking Alpha
Monday, April 20, 2009 - 4:28pm
tags:
Merck, earnings
Vion Pharmaceuticals: Onrigin application accepted but barriers remain
Pharmaceutical Business Review
Monday, April 20, 2009 - 10:56am
tags:
Vion Pharmaceuticals, Onrigin, FDA, leukemia
Biogen's Tysabri Reports 6th Case
Yahoo/Zacks.com
Monday, April 20, 2009 - 10:53am
tags:
Biogen Idec, Tysabri, MS, multiple sclerosis, PML
Galapagos signs Merck deal, shares leap
Reuters
Monday, April 20, 2009 - 10:40am
tags:
Galapagos, Merck
More FDA frustration for Discovery Labs
Bizjournals.com
Monday, April 20, 2009 - 10:39am
tags:
FDA, Discovery Labs, Surfaxin
Gilead Preview: HIV Drugs Still Focus
TheStreet.com
Monday, April 20, 2009 - 10:38am
tags:
Gilead Sciences, HIV, CV Therapeutics
Drug stocks, broad market slide on economic fears
Marketwatch
Monday, April 20, 2009 - 10:37am
tags:
drug stocks
Glaxo’s Stiefel Buy: No Blockbusters, Please
WSJ Online
Monday, April 20, 2009 - 10:36am
tags:
GSK, buyouts, Stiefel Labs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.